| Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in … J Maciejewski, C Selleri, S Anderson, NS Young | 622 | 1995 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 545 | 2020 |
| Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ... New England Journal of Medicine 374 (1), 43-53, 2016 | 524 | 2016 |
| Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab AM Risitano, R Notaro, L Marando, B Serio, D Ranaldi, E Seneca, P Ricci, ... Blood, The Journal of the American Society of Hematology 113 (17), 4094-4100, 2009 | 375 | 2009 |
| Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia JP Maciejewski, C Selleri, T Sato, S Anderson, NS Young British journal of haematology 91 (1), 245-252, 1995 | 354 | 1995 |
| Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label … PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ... The Lancet Oncology 20 (6), 781-794, 2019 | 349 | 2019 |
| Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. JP Maciejewski, C Selleri, T Sato, HJ Cho, LK Keefer, CF Nathan, ... The Journal of clinical investigation 96 (2), 1085-1092, 1995 | 300 | 1995 |
| Interferon-gamma and tumor necrosis factor-alfa suppress both early and late stages of hematopoiesis and induce programmed cell death C Selleri, S Anderson, NS Young, J Maciejewski BLOOD 84, 215-215, 1994 | 296 | 1994 |
| Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition C Selleri, JP Maciejewski, T Sato, NS Young | 281 | 1996 |
| Therapy of molecular relapse in acute promyelocytic leukemia FL Coco, D Diverio, G Avvisati, MC Petti, G Meloni, EM Pogliani, A Biondi, ... Blood, The Journal of the American Society of Hematology 94 (7), 2225-2229, 1999 | 275 | 1999 |
| WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) EP Alessandrino, MG Della Porta, A Bacigalupo, MT Van Lint, M Falda, ... BLOOD 112 (3), 895-902, 2008 | 249 | 2008 |
| Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+ 5 responders and no advantage for nonresponders receiving anti–thymocyte … MT Van Lint, G Milone, S Leotta, C Uderzo, R Scime, S Dallorso, ... Blood 107 (10), 4177-4181, 2006 | 218 | 2006 |
| High prevalence of endocrine dysfunction in long‐term survivors after allogeneic bone marrow transplantation for hematologic diseases L Tauchmanovà, C Selleri, GD Rosa, L Pagano, F Orio, G Lombardi, ... Cancer 95 (5), 1076-1084, 2002 | 206 | 2002 |
| Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia C Selleri, T Sato, L Del Vecchio, L Luciano, AJ Barrett, B Rotoli, NS Young, ... Blood 89 (3), 957-964, 1997 | 197 | 1997 |
| A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia JP Maciejewski, C Selleri, T Sato, S Anderson, NS Young | 192 | 1996 |
| Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation R Crocchiolo, E Zino, L Vago, R Oneto, B Bruno, S Pollichieni, N Sacchi, ... Blood 114 (7), 1437-1444, 2009 | 187 | 2009 |
| Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) F Patriarca, A Baciga lupo, A Sperotto, M Isola, F Soldano, B Bruno, ... HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 93 (10), 1514-1522, 2008 | 167 | 2008 |
| Extramedullary Involvement at Relapse in Acute Promyelocytic Leukemia Patients Treated or Not With All-Trans Retinoic Acid: A Report by the Gruppo Italiano … G Specchia, F Lo Coco, M Vignetti, G Avvisati, P Fazi, F Albano, ... Journal of Clinical Oncology 19 (20), 4023-4028, 2001 | 165 | 2001 |
| Mesenchymal stem cells from the Wharton’s jelly of the human umbilical cord: biological properties and therapeutic potential L Marino, MA Castaldi, R Rosamilio, E Ragni, R Vitolo, C Fulgione, ... International journal of stem cells 12 (2), 218, 2019 | 139 | 2019 |
| The urokinase-type plasminogen activator receptor involvement in hematopoietic stem cell mobilization C Selleri, N Montuori, P Ricci, V Visconte, MV Carriero, N Sidenius, ... Blood 105 (5), 2198-2205, 2005 | 137* | 2005 |
